MLchartDataset catalogue

Arranon

Term · Oncology and biomedicine · MLC-T-ONC-000723

A drug used to treat adults and children aged 1 year and older with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It is used in patients whose cancer has not gotten better or has recurred (come back) after treatment with other anticancer drugs. Arranon stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called 506U78 and nelarabine.

Table 1. Record
IdentifierMLC-T-ONC-000723
FieldOncology and biomedicine
Synonyms506U78; nelarabine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000723",
  "term": "Arranon",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults and children aged 1 year and older with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It is used in patients whose cancer has not gotten better or has recurred (come back) after treatment with other anticancer drugs. Arranon stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called 506U78 and nelarabine.",
  "synonyms": [
    "506U78",
    "nelarabine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/arranon/"
}

Record 2,446 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.